Asahi Kasei Corporation
Stock Price Chart
2026/01/16 UpdatedPrice Trend
2026/01/16 UpdatedPrice & Trading Details
2026/01/16 UpdatedPRICE
TRADING
Analyst Recommendations 12 analysts
Updated 2026/01/11Shareholder Composition
Updated 2026/01/11Top Mutual Funds / ETFs
Updated 2026/01/11Major Holders
Updated 2026/01/11| Fund Name | Ownership | Shares | Change |
|---|---|---|---|
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
18.2M | +0.47% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
11.5M | +2.96% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
8.4M | +1.24% | |
|
Fidelity Concord Street Trust-Fidelity International Index Fund
|
4.6M | +5.39% | |
|
iShares, Inc.-iShares MSCI Japan ETF
|
4.5M | +7.22% | |
|
Dimensional ETF Trust-Dimensional International Value ETF
|
4.4M | +5.73% |
| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
Pacer Advisors, Inc.
|
581.2K | +2.06% |
Dividend History 1Years Growth
Updated 2026/01/11| Year | Dividend | Change |
|---|---|---|
| 2025 | ¥40 | +11.1% |
| 2024 | ¥36 | 0.0% |
| 2023 | ¥36 | +2.9% |
| 2022 | ¥35 | +2.9% |
| 2021 | ¥34 | - |
Financial Performance
2026/01/11 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥2,461,317M | ¥2,726,485M | ¥2,784,878M | ¥3,037,312M |
| Gross Profit | ¥769,769M | ¥773,776M | ¥815,969M | ¥958,260M |
| Operating Income | ¥202,647M | ¥127,716M | ¥140,746M | ¥211,920M |
| Pretax Income | ¥218,764M | -¥56,634M | ¥36,291M | ¥203,698M |
| Net Income | ¥161,880M | -¥91,947M | ¥43,806M | ¥134,997M |
| EPS | ¥116.68 | -¥66.30 | ¥31.60 | ¥99.40 |
| Operating Margin | 8.23% | 4.68% | 5.05% | 6.98% |
| Balance Sheet | ||||
| Total Assets | ¥3,349,075M | ¥3,453,900M | ¥3,662,730M | ¥4,015,214M |
| Total Equity | ¥1,687,411M | ¥1,660,296M | ¥1,813,391M | ¥1,859,421M |
| Total Liabilities | ¥1,661,664M | ¥1,793,604M | ¥1,849,339M | ¥2,155,793M |
| Cash | ¥244,641M | ¥251,181M | ¥338,108M | ¥393,467M |
| Interest-bearing Debt | ¥777,215M | ¥974,748M | ¥955,561M | ¥1,195,045M |
| Equity Ratio | 50.38% | 48.07% | 49.51% | 46.31% |
| D/E Ratio | 0.46 | 0.59 | 0.53 | 0.64 |
| Cash Flow | ||||
| Operating CF | ¥183,271M | ¥90,804M | ¥295,300M | ¥301,489M |
| Investing CF | -¥221,019M | -¥213,584M | -¥142,598M | -¥381,150M |
| Financing CF | ¥42,321M | ¥111,780M | -¥94,331M | ¥144,567M |
| Free CF | ¥13,563M | -¥81,354M | ¥123,346M | ¥83,550M |
| Efficiency | ||||
| ROE | 9.59% | -5.54% | 2.42% | 7.26% |
| ROA | 4.83% | -2.66% | 1.20% | 3.36% |
Latest News (5 items)
-
Average Analyst Rating: buy
Average Target Price: ¥1,503
Rating Score: 1.75 (Based on 12 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Asahi Kasei Corporation engages in material, homes, healthcare businesses. The company offers Pimel photosensitive polyimide/PBO precursor, a liquid photosensitive material for buffer coating and packaging applications; Sunfort dry film photoresist to form circuit patterns on printed wiring boards; Novacure, a latent curing agent for epoxy resin with storage stability; glass fabric for printed circuit boards; plastic optical fiber; suede products under the Dinamica name; Microza UF and MF industrial membranes and systems; Aciplex membranes, process equipment, and systems for caustic soda production; Hipore, a microporous polyolefin sheet which prevents the anode and cathode from contacting one another; Celgard, a lithium-ion battery separator; Deramic, a lead acid battery separator; photopolymers and platemaking systems; and fiber products under the Bemberg, ROICA, ELTAS, Bemliese, EUTEC, Precisé, SEMIA, smash, PULSHUT, Lastan, Cubit, NanoAct, ECORISE, BioCradle, CMC-Bemliese names. It also provides cling film, bags and containers, and dishwashing liquid under the Saran Wrap, Ziploc, Cookper, Frosch names; packaging products under the OPS, Suntec, Barrialon, PVDC latex, and Saran names; pharmaceutical and food additives under the Ceolous and Celphere names; and clads and anchors under the Baclad and AR Chemical Setter names. In addition, the company is involved in the provision of remodeling services; real estate-related operations; offers unit homes and apartment buildings; autoclaved aerated concrete, foundation systems, thermal insulation material, structural systems and components products; prescription drugs in the fields of orthopedics, critical/intensive care, urology, immune system, and central nervous system; enzymes and diagnostic products; and hemodialysis, therapeutic apheresis, and autologous blood-related businesses. The company was founded in 1931 and is headquartered in Tokyo, Japan.